
GTCR completes sale of Cord Blood Registry to AMAG Pharmaceuticals
Private equity firm GTCR has completed the previously announced sale of its portfolio company Cord Blood Registry (CBR) to AMAG Pharmaceuticals (AMAG), a specialty pharmaceutical company that focuses on maternal health and haematology, for USD700 million. Founded in 1992, CBR is the world’s largest newborn stem cell company, entrusted by